+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biological Safety Testing Market Research and Forecast, 2019-2025

  • ID: 4753705
  • Report
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Avance Biosciences Inc.
  • Creative Biogene
  • Eurofins Scientific
  • Merck KGaA
  • NuAire Inc.
  • Toxikon Corp.
  • MORE
Global Biological Safety Testing Market Size, Share & Trends Analysis Report by Product (Instruments, and Reagents & kits), by Test Type (Sterility Test, Bioburden Test, and Others), And Segment Forecasts, 2019 - 2025.

Global biological safety testing market is primarily driven by rising number of biological developments due to ongoing research in the biotechnology industry in order to develop products and services. Safety procedures are continuously being adopted for the testing purpose. With the development of new biological products, safety testing for ensuring non-contamination is mandatory due to stringent regulations imposed by government authorities. Stringent regulations are supporting the growth for global biological safety testing market. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), are some of the organizations responsible for regulatory concerns. Regulatory bodies curtail the circulation of counterfeit drugs and equipment and promote genuine products by declaring obligatory guidelines for biological safety testing. The rising number of biotechnology companies across the globe is augmenting the demand for safety testing. With the increasing demand for biotechnology, market players are increasing investments in the research by developing collaborations with research institutes. Growing research activities in the biotechnology are estimated to grow global biological safety testing market substantially.

Life science research is prevalent in North America due to the presence of market players in the US and Canada. North America is dominating the global biological safety testing market. Research institutes are advancing the technology by increasing investment in the biotechnology sector in the region. Europe contributes significantly to the market. Governments are supporting the European countries to develop in the biotechnology research. Asia-Pacific is pacing towards biotechnology research. The region is estimated to grow at a substantial rate during the forecast period. Increasing awareness among people for various healthcare services and technologies is supporting the growth of the Asia-Pacific region. Increasing medical tourism in the region is providing a surge in the funding and reimbursement policies for healthcare technologies.

The market is comprised of some major market players including Merck KGaA, NuAire Inc., Lonza Group Ltd., Charles River Laboratories Inc., Neopharm Labs Inc., Sartorius Stedim BioOutsource Ltd., SGS SA, and others. Companies are focusing on investment in biotechnology in order to gain a competitive edge in the market. Collaboration with research laboratories remains the key strategy for strengthening healthcare service offerings.

Research Methodology

The market study of the global biological safety testing market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the publisher's.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases such
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.
The report is intended for biotech and pharmaceutical companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

Global biological safety testing market is segmented on the basis of regional outlook and following segments:
1. Global Biological Safety Testing Market Research and Analysis by Product
2. Global Biological Safety Testing Market Research and Analysis by Test Type
3. Global Biological Safety Testing Market Research and Analysis by Geography

The Report Covers:
  • Comprehensive research methodology of the global biological safety testing market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global biological safety testing market.
  • Insights about market determinants which are stimulating the global biological safety testing market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Avance Biosciences Inc.
  • Creative Biogene
  • Eurofins Scientific
  • Merck KGaA
  • NuAire Inc.
  • Toxikon Corp.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Charles River Laboratories Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. WuXi PharmaTech Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Thermo Fisher Scientific Inc.,
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Toxikon Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Merck KGaA
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Biological Safety Testing Market by Product
5.1.1. Instruments
5.1.2. Reagents & Kits
5.2. Global Biological Safety Testing Market by Test Type
5.2.1. Sterility Test
5.2.2. Bioburden Test
5.2.3. Residual Host Contamination Detection Test
5.2.4. Cell Line Authentication and Characterization Test
5.2.5. Others

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Avance Biosciences Inc.
7.2. B&V Testing, Inc.
7.3. Charles River Laboratories Inc.
7.4. Creative Biogene
7.5. Creative BioMart
7.6. Eurofins Scientific
7.7. Lonza Group Ltd.
7.8. Merck KGaA
7.9. Neopharm Labs Inc.
7.10. NuAire Inc.
7.11. Sartorius Stedim BioOutsource Ltd.
7.12. SGS SA
7.13. Thermo Fisher Scientific Inc.
7.14. Toxikon Corp.
7.15. ViruSure GmbH
7.16. WuXi PharmaTech Inc.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Avance Biosciences Inc.
  • B&V Testing, Inc.
  • Charles River Laboratories Inc.
  • Creative Biogene
  • Creative BioMart
  • Eurofins Scientific
  • Lonza Group Ltd.
  • Merck KGaA
  • Neopharm Labs Inc.
  • NuAire Inc.
  • Sartorius Stedim BioOutsource Ltd.
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • Toxikon Corp.
  • ViruSure GmbH
  • WuXi PharmaTech Inc.
Note: Product cover images may vary from those shown
Adroll
adroll